Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;88(5):983-998.
doi: 10.1016/j.jaad.2022.07.063. Epub 2022 Aug 29.

An update on Epstein-Barr virus-and human T-lymphotropic virus type-1-induced cutaneous manifestations. CME Part II

Affiliations
Review

An update on Epstein-Barr virus-and human T-lymphotropic virus type-1-induced cutaneous manifestations. CME Part II

Alejandro A Gru et al. J Am Acad Dermatol. 2023 May.

Abstract

The Epstein-Barr virus (EBV) is a DNA virus that infects 90% of the human population, is responsible for certain cutaneous lymphomas (extranodal NK/T-cell lymhoma, hydroa vacciniforme lymphoproliferative disorder, lymphomatoid granulomatosis, others), and can be associated with a variety of cutaneous manifestations (eg, infectious mononucleosis, severe mosquito bite allergy, chronic active EBV disease, Gianotti-Crosti syndrome). EBV-related skin disorders are frequent in certain populations (South and Cental America, Africa, Asia, and Oceania) and can be diagnostically challenging. The human T-lymphotropic virus type-1 is a retrovirus, which is known to be associated with adult T-cell leukemia/lymphoma, neurologic disorders, but also cutaneous non-neoplastic manifestations (infective dermatitis, infections, and infestations). We performed an updated revision of the clinical dermatologic and histopathologic findings associated with the cutaneous non-neoplastic and preneoplastic disorders occurring in association with the EBV and human T-lymphotropic virus type-1.

Keywords: Gianotti-Crosti syndrome; Lipschutz ulcer; chronic active EBV disease; infectious mononucleosis; infective dermatitis; infestations; severe mosquito bite allergy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Alejandro A Gru is a coinvestigator for Innate Pharma and CRISPR Therapeutics; a coinvestigator, advisory board member, consultant, speaker for StemLine Therapeutics; and a consultant for Kyowa Kirin. JA Plaza, JA Sanches, D Miyashiro, OP Sangueza, F Bravo, S Toussaint, and JM Sangueza have no conflicts of interest to declare.

MeSH terms

LinkOut - more resources